{
    "clinical_study": {
        "@rank": "8158", 
        "arm_group": [
            {
                "arm_group_label": "Anterior Approach Total Hip", 
                "arm_group_type": "Experimental", 
                "description": "Total hip arthroplasty performed through an anterior surgical approach."
            }, 
            {
                "arm_group_label": "Posterior Approach Total Hip", 
                "arm_group_type": "Active Comparator", 
                "description": "The additional arm is the posterior approach total hip, which the Anterior Approach is being compared too"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the short term effectiveness and return to function\n      of subjects undergoing primary Total Hip Arthroplasty using an Anterior Approach (incision\n      on the front part of the hip joint) versus Posterior Approach (incision over back part of\n      the hip joint)."
        }, 
        "brief_title": "Total Hip Arthroplasty (THA) Surgical Techniques Comparing the Direct Anterior Approach to the Posterior Approach", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Osteoarthritis of the Hip", 
        "condition_browse": {
            "mesh_term": [
                "Osteoarthritis", 
                "Osteoarthritis, Hip"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subject is able to or capable of providing consent to participate in the clinical\n             investigation.\n\n          2. Subject is between the ages of 20-75 years, inclusive.\n\n          3. Subject requires a cementless, primary total hip arthroplasty for non-inflammatory\n             degenerative joint disease (NIDJD)\n\n          4. Subject has sufficient bone stock for the hip replacement device.\n\n          5. Subject is a suitable candidate for the devices specified in the clinical\n             investigation plan and is willing to be randomized to either surgical approach.\n\n        Exclusion Criteria:\n\n          1. Subject in the opinion of the Investigator has an existing condition that would\n             compromise his /her participation and follow-up in this investigation.\n\n          2. Subject has had previous surgery on the affected hip.\n\n          3. Subject has significant osteoarthritis of the contra-lateral hip requiring a total\n             hip arthroplasty within 12 months."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "88", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 16, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01807104", 
            "org_study_id": "20091819"
        }, 
        "intervention": [
            {
                "arm_group_label": "Anterior Approach Total Hip", 
                "description": "compare results of total hip arthroplasty performed through either an anterior or posterior surgical approach", 
                "intervention_name": "Anterior Approach / Posterior Approach", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Posterior Approach Total Hip", 
                "intervention_name": "Anterior versus Posterior Approach for total hip replacement", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Anterior Approach", 
            "Posterior Approach"
        ], 
        "lastchanged_date": "March 6, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Renton", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "98055"
                }, 
                "name": "Valley Orthopedic Associates"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective Randomized Single Center Clinical Evaluation of THA Surgical Techniques Comparing the Direct Anterior Approach to the Posterior Approach", 
        "overall_official": {
            "last_name": "William P Barrett, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Functional activities (distance walked, assistive devices used) Length of hospital stay/Harris Hip Score Elements/Hip disability and Osteoarthritis Outcome Score/Timed walking tests/Complications/Patient Withdrawal/Revision/Deaths (as applicable) At Two years, we will measure Harris Hip Score,UCLA activity score, and Radiographic evalution score.\nAt 5 years, we will measure Harris Hip Score, UCLA activity score and Radiographic evaluation score.\nAt each time interval we will evaluate expected non-interval change between the Anterior and Posterior approach.  The outcome measures at 2 and 5 years have been validated outcome measures for joint replacement surgery for peer reviewed orthopedic literature.\nNote: The outcome we are measuring at each interval is to return to quality of life as measured by the validated outcome measures noted above.  Thus we are measuring one outcome at each interval.", 
            "measure": "Returning to Quality of Life by using either Anterior Approach versus Posterior Approach", 
            "safety_issue": "No", 
            "time_frame": "up to 5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01807104"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Barrett, William, M.D.", 
            "investigator_full_name": "William Barrett, M.D.", 
            "investigator_title": "William Barrett,M.D,", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Barrett, William, M.D.", 
        "sponsors": {
            "collaborator": {
                "agency": "Johnson & Johnson", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Barrett, William, M.D.", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}